ZURA
Zura Bio Ltd
Company overview
- Market capitalization
- $392.90M
- Employees
- 40
- Latest publication
- 2026-09-29
About Zura Bio Ltd
Zura Bio Limited, a clinical-stage biotechnology company, develops medicines for autoimmune and inflammatory disorders in the United States. The company develops Tibulizumab, a humanized IgG4 single-chain variable fragment bispecific antibody engineered to bind and neutralize both IL-17A and BAFF within a single therapeutic molecule, which is in Phase 2 clinical trial development. It also develops Torudokimab (ZB-880), a fully human immunoglobulin G4 monoclonal antibody targeting interleukin-33 that has completed Phase 1 clinical studies; and Crebankitug (ZB-168), a fully human immunoglobulin G1 monoclonal antibody targeting interleukin-7 receptor alpha that has completed Phase 1 clinical studies. Zura Bio Limited was founded in 2022 and is headquartered in Henderson, Nevada.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 14,746,000USD | — | 11,948,000USD | 8,704,000USD | 10,474,000USD | 9,240,000USD | 6,029,000USD | 5,539,000USD |
| Total Operating Expenses | 25,499,000USD | — | 19,519,000USD | 18,062,000USD | 19,254,000USD | 15,727,000USD | 19,319,000USD | 11,759,000USD |
| Net Income | -24,223,000USD | -99,400,000USD | -18,040,000USD | -15,993,000USD | -17,442,000USD | -9,048,000USD | -20,702,000USD | -10,329,000USD |
| Total Revenue | — | — | — | — | 0USD | 2,000USD | 0USD | 0USD |
| Cost Of Revenue | — | — | — | — | 9,000USD | 5,000USD | 3,000USD | 1,000USD |
| Gross Profit | — | — | — | — | -9,000USD | -5,000USD | -3,000USD | -1,000USD |
| Selling General Administrative | — | — | — | — | 8,780,000USD | 6,492,000USD | 13,290,000USD | 6,220,000USD |
| Operating Income | — | — | — | — | -19,254,000USD | -15,732,000USD | -19,319,000USD | -11,759,000USD |
| Interest Income | — | — | — | — | 1,817,000USD | 2,126,000USD | 2,461,000USD | 2,196,000USD |
| Net Interest Income | — | — | — | — | 1,817,000USD | 2,126,000USD | 2,461,000USD | 2,196,000USD |
| Income Before Tax | — | — | — | — | -17,442,000USD | -13,625,000USD | -20,702,000USD | -10,329,000USD |
| Tax Provision | — | — | — | — | 0USD | 0USD | 0USD | 0USD |
| Net Income From Continuing Ops | — | — | — | — | -17,442,000USD | -13,625,000USD | -20,702,000USD | -10,329,000USD |
| Ebit | — | — | — | — | -19,254,000USD | -13,625,000USD | -19,319,000USD | -11,759,000USD |
| Ebitda | — | — | — | — | -19,245,000USD | -13,620,000USD | -19,316,000USD | -11,758,000USD |
| Depreciation And Amortization | — | — | — | — | 9,000USD | 5,000USD | 3,000USD | 1,000USD |
| Reconciled Depreciation | — | — | — | — | 9,000USD | 5,000USD | 3,000USD | 1,000USD |
| Total Other Income Expense Net | — | — | — | — | 1,812,000USD | 2,107,000USD | -1,383,000USD | 1,430,000USD |
| Minority Interest | — | — | — | — | — | 0USD | 0USD | 0USD |
| Income Tax Expense | — | — | — | — | — | — | 2,240,000USD | 2,337,000USD |
| Source | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | — |
| Cost Of Revenue | 49,000USD | 9,000USD | — | — | — |
| Gross Profit | -49,000USD | -9,000USD | — | — | — |
| Research Development | 42,082,000USD | 24,401,000USD | 43,999,000USD | 23,689,000USD | — |
| Selling General Administrative | 33,164,000USD | 30,788,000USD | 18,639,000USD | 3,473,000USD | — |
| Total Operating Expenses | 75,246,000USD | 55,189,000USD | 62,638,000USD | 27,162,000USD | 1,091,986USD |
| Operating Income | -75,246,000USD | -55,189,000USD | -62,638,000USD | -27,162,000USD | -1,091,986USD |
| Interest Income | 6,336,000USD | 7,998,000USD | 2,186,000USD | 570USD | — |
| Net Interest Income | 6,336,000USD | 7,998,000USD | 2,186,000USD | 570USD | — |
| Income Before Tax | -68,650,000USD | -52,403,000USD | -60,563,000USD | -27,333,000USD | 8,416,710USD |
| Income Tax Expense | 30,703,000USD | -7,017,000USD | -203,000USD | -570USD | -236,558USD |
| Tax Provision | 0USD | 0USD | 0USD | 0USD | — |
| Net Income | -68,650,000USD | -52,403,000USD | -60,360,000USD | -25,738,000USD | 8,416,710USD |
| Net Income From Continuing Ops | -68,650,000USD | -52,403,000USD | -60,563,000USD | -27,333,000USD | — |
| Ebit | -75,246,000USD | -55,189,000USD | -60,563,000USD | -27,333,000USD | 8,416,710USD |
| Ebitda | -75,197,000USD | -55,180,000USD | -62,638,000USD | -27,162,000USD | 8,416,710USD |
| Depreciation And Amortization | 49,000USD | 9,000USD | 167,895USD | 228,485USD | 236,558USD |
| Reconciled Depreciation | 49,000USD | 9,000USD | 0USD | — | — |
| Total Other Income Expense Net | 6,596,000USD | 2,786,000USD | 2,075,000USD | -171,000USD | 9,508,697USD |
| Minority Interest | — | 0USD | 203,000USD | 1,595,000USD | — |
| Net Income Applicable To Common Shares | — | — | — | -35,334,543USD | -46,914,000USD |
| Unclassified Operating Expenses | — | — | — | — | 1,091,986USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 213,403,000USD | 228,641,000USD | 113,948,000USD | 143,935,000USD | 157,805,000USD | 172,496,000USD | 179,533,000USD | 189,071,000USD |
| Cash And Equivalents | 205,134,000USD | 225,594,000USD | 109,407,000USD | 139,017,000USD | 154,490,000USD | — | — | — |
| Total Current Assets | 210,500,000USD | 227,004,000USD | 112,310,000USD | 142,292,000USD | 156,985,000USD | 171,692,000USD | 178,744,000USD | 188,975,000USD |
| Other Current Assets | 5,366,000USD | 1,410,000USD | 2,903,000USD | 3,275,000USD | 2,495,000USD | 1,123,000USD | 2,246,000USD | 754,000USD |
| Other Non Current Assets | 2,754,000USD | 1,512,000USD | 1,512,000USD | 1,512,000USD | 698,000USD | — | — | — |
| Total Liabilities | 16,318,000USD | 11,745,000USD | 12,410,000USD | 25,491,000USD | 18,696,000USD | — | — | — |
| Total Current Liabilities | 16,318,000USD | 11,745,000USD | 12,410,000USD | 25,491,000USD | 18,696,000USD | 21,092,000USD | 19,514,000USD | 18,244,000USD |
| Total Equity Including Noncontrolling Interest | 197,085,000USD | 216,896,000USD | 101,538,000USD | 118,444,000USD | 139,109,000USD | — | — | — |
| Property Plant Equipment Net | 149,000USD | 125,000USD | 126,000USD | 131,000USD | 122,000USD | 106,000USD | 91,000USD | 44,000USD |
| Accounts Payable | 3,283,000USD | 2,083,000USD | 1,279,000USD | 3,275,000USD | 1,205,000USD | 1,249,000USD | 733,000USD | 1,014,000USD |
| Common Stock | 10,000USD | 9,000USD | 7,000USD | 7,000USD | 6,000USD | 7,000USD | 7,000USD | 7,000USD |
| Retained Earnings | -275,074,000USD | -248,770,000USD | -224,547,000USD | -207,372,000USD | -189,332,000USD | -173,339,000USD | -155,897,000USD | -142,272,000USD |
| Total Stockholder Equity | — | — | 101,538,000USD | 108,243,000USD | 125,905,000USD | 138,200,000USD | 146,815,000USD | 153,046,000USD |
| Total Liab | — | — | — | — | — | 21,092,000USD | 19,514,000USD | 18,244,000USD |
| Other Current Liab | — | — | — | — | — | 19,843,000USD | 18,781,000USD | 16,646,000USD |
| Capital Stock | — | — | — | — | — | 7,000USD | 7,000USD | 7,000USD |
| Cash | — | — | — | — | — | 170,569,000USD | 176,498,000USD | 188,221,000USD |
| Cash And Short Term Investments | — | — | — | — | — | 170,569,000USD | 176,498,000USD | 188,221,000USD |
| Net Debt | — | — | — | — | — | -170,569,000USD | -176,498,000USD | -188,221,000USD |
| Common Stock Shares Outstanding | — | — | — | — | — | 65,297,529shares | 65,297,529shares | 87,335,667shares |
| Non Current Assets Total | — | — | — | — | — | 804,000USD | 789,000USD | 96,000USD |
| Non Current Liabilities Total | — | — | — | — | — | 0USD | 0USD | 0USD |
| Non Currrent Assets Other | — | — | — | — | — | 698,000USD | 698,000USD | 52,000USD |
| Net Working Capital | — | — | — | — | — | 150,600,000USD | 159,230,000USD | 170,731,000USD |
| Unclassified Equity | — | — | — | — | — | 311,525,000USD | 302,698,000USD | 295,304,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Total Assets | 113,948,000USD | 179,533,000USD | 100,843,000USD | 5,262,000USD | 140,551,171USD |
| Cash And Equivalents | 109,407,000USD | — | — | — | — |
| Total Current Assets | 112,310,000USD | 178,744,000USD | 100,843,000USD | 1,776,000USD | 1,152,117USD |
| Other Current Assets | 2,903,000USD | 2,246,000USD | 1,037,000USD | 209,000USD | 422,894USD |
| Other Non Current Assets | 1,512,000USD | — | — | — | — |
| Total Liabilities | 12,410,000USD | — | — | — | — |
| Total Current Liabilities | 12,410,000USD | 19,514,000USD | 20,302,000USD | 14,818,000USD | 272,292USD |
| Total Stockholder Equity | 101,538,000USD | 146,815,000USD | 59,330,000USD | -32,056,000USD | 130,198,979USD |
| Total Equity Including Noncontrolling Interest | 101,538,000USD | — | — | — | — |
| Property Plant Equipment Net | 126,000USD | 91,000USD | 0USD | — | — |
| Accounts Payable | 1,279,000USD | 733,000USD | 2,749,000USD | 2,010,000USD | 7,000USD |
| Common Stock | 7,000USD | 7,000USD | 4,000USD | 141,374,697USD | 139,380,345USD |
| Retained Earnings | -224,547,000USD | -155,897,000USD | -103,494,000USD | -32,056,000USD | -9,181,366USD |
| Total Liab | — | 19,514,000USD | 21,292,000USD | 27,318,000USD | 10,352,192USD |
| Other Current Liab | — | 18,781,000USD | 17,553,000USD | 5,052,000USD | 272,292USD |
| Capital Stock | — | 7,000USD | 4,000USD | 141,374,697USD | 139,380,345USD |
| Cash | — | 176,498,000USD | 99,806,000USD | 1,567,000USD | 729,223USD |
| Cash And Short Term Investments | — | 176,498,000USD | 99,806,000USD | 1,567,000USD | 729,223USD |
| Net Debt | — | -176,498,000USD | -99,806,000USD | 6,189,000USD | -729,223USD |
| Common Stock Shares Outstanding | — | 75,070,761shares | 33,064,036shares | 17,250,000shares | 17,250,000shares |
| Non Current Assets Total | — | 789,000USD | 0USD | 3,486,000USD | 139,399,054USD |
| Non Current Liabilities Total | — | 0USD | 990,000USD | 12,500,000USD | 10,079,900USD |
| Non Currrent Assets Other | — | 698,000USD | — | 3,486,000USD | 139,399,054USD |
| Net Working Capital | — | 159,230,000USD | 80,541,000USD | -1,794,746USD | 4,681,000USD |
| Unclassified Equity | — | 302,698,000USD | 162,816,000USD | -282,749,394USD | 139,380,345USD |
| Deferred Long Term Liab | — | — | — | 3,486,000USD | — |
| Other Assets | — | — | — | 141,474,352USD | -139,399,054USD |
| Current Deferred Revenue | — | — | — | -355,595USD | — |
| Short Term Debt | — | — | — | 7,756,000USD | — |
| Short Long Term Debt | — | — | — | 355,595USD | — |
| Short Long Term Debt Total | — | — | — | 7,756,000USD | — |
| Net Tangible Assets | — | — | — | -32,056,000USD | -7,819,000USD |
| Unclassified Non Current Assets | — | — | — | -141,474,352USD | — |
| Unclassified Non Current Liabilities | — | — | — | 9,014,000USD | 10,079,900USD |
| Accumulated Other Comprehensive Income | — | — | — | — | -278,760,690USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD |
|---|---|---|---|
| Depreciation | 32USD | 34,000USD | 20,000USD |
| Stock Based Compensation | 9,465USD | 9,755,000USD | 7,376,000USD |
| Deferred Income Tax | -2,753USD | — | — |
| Change To Liabilities | 3,740USD | 919,000USD | -872,000USD |
| Change In Working Capital | 3,908USD | -924,000USD | -1,121,000USD |
| Operating Cash Flow | -39,824USD | -42,537,000USD | -27,093,000USD |
| Capital Expenditures | -37USD | -96,000USD | -64,000USD |
| Investing Cash Flow | -37USD | -96,000USD | -64,000USD |
| Net Common Stock Issuance | 0USD | -34,000USD | -34,000USD |
| Unclassified Financing Cash Flow | 135,588USD | 5,186,000USD | 5,183,000USD |
| Financing Cash Flow | 135,588USD | 5,152,000USD | 5,149,000USD |
| Change In Cash | 95,727USD | -37,481,000USD | -22,008,000USD |
| End Cash Flow | 205,134USD | 139,017,000USD | 154,490,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Depreciation | 16,000USD | 15,000USD | 14,000USD | 11,000USD | 9,000USD | 5,000USD | 3,000USD | 1,000USD |
| Stock Based Compensation | 5,008,000USD | 2,577,000USD | 2,379,000USD | 3,732,000USD | 3,644,000USD | 2,817,000USD | 8,646,000USD | 2,926,000USD |
| Change To Liabilities | -1,222,000USD | — | — | — | — | — | — | — |
| Change In Working Capital | 271,000USD | -2,710,000USD | 197,000USD | -3,823,000USD | 2,702,000USD | -25,000USD | 2,540,000USD | 19,000USD |
| Operating Cash Flow | -18,923,000USD | — | — | — | — | — | — | — |
| Capital Expenditures | -13,000USD | -17,000USD | -31,999USD | -15,000USD | -49,000USD | -45,000USD | -13,000USD | -10,000USD |
| Investing Cash Flow | -13,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 135,123,000USD | — | — | — | — | — | — | — |
| Change In Cash | 116,187,000USD | -29,610,000USD | -15,473,000USD | -16,079,000USD | -5,929,000USD | -11,723,000USD | -222,000USD | 98,626,000USD |
| End Cash Flow | 225,594,000USD | — | — | — | — | — | — | — |
| Net Income | — | -17,175,000USD | -20,037,000USD | -15,993,000USD | -17,442,000USD | -11,288,000USD | -20,702,000USD | -12,666,000USD |
| Other Non Cash Items | — | -4,985,000USD | 4,382,000USD | 43,000USD | 24,000USD | -2,333,000USD | 3,860,000USD | 3,104,000USD |
| Total Cash From Operating Activities | — | -22,278,000USD | -15,444,000USD | -16,030,000USD | -11,063,000USD | -10,824,000USD | -5,653,000USD | -6,617,000USD |
| Free Cash Flow | — | -22,295,000USD | -15,476,000USD | -16,045,000USD | -11,112,000USD | -10,869,000USD | -5,666,000USD | -6,627,000USD |
| Total Cashflows From Investing Activities | — | -17,000USD | -32,000USD | -15,000USD | -49,000USD | -45,000USD | -13,000USD | -10,000USD |
| Total Cash From Financing Activities | — | -7,315,000USD | 3,000USD | -34,000USD | 5,183,000USD | -854,000USD | 5,444,000USD | 105,253,000USD |
| Issuance Of Capital Stock | — | 3,000USD | 0USD | 0USD | 5,093,000USD | 0USD | 5,534,000USD | 55,223,000USD |
| Begin Period Cash Flow | — | 139,017,000USD | 154,490,000USD | 170,569,000USD | 176,498,000USD | 188,221,000USD | 188,443,000USD | 89,817,000USD |
| End Period Cash Flow | — | 109,407,000USD | 139,017,000USD | 154,490,000USD | 170,569,000USD | 176,498,000USD | 188,221,000USD | 188,443,000USD |
| Other Cashflows From Financing Activities | — | -7,332,000USD | 3,000USD | -34,000USD | 90,000USD | 59,903,000USD | -90,000USD | 50,030,000USD |
| Investments | — | — | -32,000USD | -15,000USD | -49,000USD | -45,000USD | -13,000USD | -10,000USD |
| Unclassified Operating Cash Flow | — | — | -2,379,000USD | — | — | — | — | — |
| Net Borrowings | — | — | — | — | — | 0USD | 0USD | — |
| Other Cashflows From Investing Activities | — | — | — | — | — | -5,000,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | — | — | 5,045,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | -60,757,000USD | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD |
|---|---|---|---|---|---|
| Depreciation | 49,000USD | 9,000USD | 0USD | — | — |
| Stock Based Compensation | 12,332,000USD | 16,798,000USD | 9,655,000USD | 334,000USD | — |
| Other Non Cash Items | 4,996,000USD | 5,213,000USD | 30,738,000USD | 22,256,000USD | -9,279,254USD |
| Change To Liabilities | -2,163,000USD | — | — | 4,090,909USD | 234,000USD |
| Change In Working Capital | -3,634,000USD | 2,307,000USD | 5,116,000USD | 3,541,000USD | -235,602USD |
| Operating Cash Flow | -64,815,000USD | — | — | — | — |
| Capital Expenditures | -113,000USD | -75,000USD | -8,000,000USD | -12,000,000USD | -4USD |
| Investing Cash Flow | -113,000USD | — | — | — | — |
| Net Common Stock Issuance | -41,000USD | — | — | — | — |
| Unclassified Financing Cash Flow | -2,122,000USD | — | — | -10,690,908USD | 132,411,461USD |
| Financing Cash Flow | -2,163,000USD | — | — | — | — |
| Change In Cash | -67,091,000USD | 76,692,000USD | 98,239,000USD | 1,567,000USD | 729,223USD |
| End Cash Flow | 109,407,000USD | — | — | — | — |
| Net Income | — | -52,403,000USD | -60,563,000USD | -27,333,000USD | 8,416,710USD |
| Total Cash From Operating Activities | — | -28,076,000USD | -15,054,000USD | -1,202,000USD | -1,098,146USD |
| Free Cash Flow | — | -28,151,000USD | -23,054,000USD | -13,202,000USD | -1,098,150USD |
| Investments | — | -5,075,000USD | -8,000,000USD | -12,000,000USD | — |
| Total Cashflows From Investing Activities | — | -5,075,000USD | -8,000,000USD | -12,000,000USD | -139,380,000USD |
| Net Borrowings | — | 0USD | -10,000,000USD | 8,290,908USD | 8,290,908USD |
| Total Cash From Financing Activities | — | 109,843,000USD | 121,293,000USD | 14,769,000USD | 141,207,369USD |
| Issuance Of Capital Stock | — | 60,757,000USD | 116,407,000USD | 10,000,000USD | — |
| Begin Period Cash Flow | — | 99,806,000USD | 1,567,000USD | 729,223USD | — |
| End Period Cash Flow | — | 176,498,000USD | 99,806,000USD | 1,567,000USD | 729,223USD |
| Other Cashflows From Investing Activities | — | -5,000,000USD | -8,000,000USD | — | — |
| Other Cashflows From Financing Activities | — | 49,086,000USD | 14,886,000USD | 7,169,000USD | 505,000USD |
| Unclassified Investing Cash Flow | — | 5,075,000USD | 16,000,000USD | 12,000,000USD | -139,379,996USD |
| Change To Account Receivables | — | — | — | — | 2,872USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.